M&A Deal Summary |
|
|---|---|
| Date | 2007-01-01 |
| Target | ribosepharm |
| Sector | Medical Products |
| Buyer(s) | Hikma |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1978 |
| Sector | Medical Products |
| Employees | 9,500 |
| Revenue | 3.1B USD (2024) |
Hikma develops, manufactures, and markets a broad range of branded and non-branded generic and in-licensed products. Hikma operates through three businesses: “Branded”, “Injectables”, and “Generics”, based principally in the Middle East and North Africa (MENA), where it is a market leader, the United States, and Europe. Hikma was founded in 1978 and is based in London, England.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 10 |
| Sector: Medical Products M&A | 2 of 5 |
| Type: Add-on Acquisition M&A Deals | 2 of 8 |
| Country: Germany M&A | 1 of 2 |
| Year: 2007 M&A | 1 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 1991-01-01 |
West-Ward Pharmaceutical
Eatontown, New Jersey, United States West-Ward Pharmaceuticals is a generic prescription medication providers in the US offering both oral solid and injectable pharmaceuticals to a growing number of chain stores, wholesalers, distributors, health systems and government agencies. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2007-05-31 |
Thymoorgan Pharmazie
Vienenburg, Germany Thymoorgan Pharmazie GmbH is a manufacturer of liquid and freeze-dried parenterals. |
Buy | - |
